ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

STAA vs EYE // DIVIDEND YIELD & FCF PAYOUT SAFETY

STAAR Surgical Company (NASDAQ) VS. National Vision Holdings Inc. (NASDAQ) • 15-METRIC TALLY: STAA 1 — EYE 7
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (STAA VS. EYE) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC STAA EYE SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 76.20% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% 4.40% -39.40 EYE /roic <GO>
EV/EBITDA & P/E Valuation — 12.4x — TIE /valuation <GO>
Free Cash Flow Yield -3.16% 5.58% -8.74 EYE /fcf-yield <GO>
Operating Margin -38.30% 3.00% -41.30 EYE /operating-margins <GO>
Net Profit Margin -33.60% 1.50% -35.10 EYE /net-margins <GO>
Revenue Growth (YoY) -23.70% 9.00% -32.70 EYE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety ACTIVE 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 7.11 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 7/9 -4.00 EYE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 65.1 46.0 +19.10 STAA /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 41.3x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $1.27B $1.32B -$50.1M EYE /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR STAA REV EYE REV STAA GROSS % EYE GROSS % STAA FCF EYE FCF
FY 2025 $239.4M $1.99B 76.2% — -$40.0M $73.5M
FY 2024 $313.9M $1.82B 76.3% — -$7.7M $38.1M
FY 2023 $322.4M $1.76B — — $14.6M $173.0M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
STAA // BETA —
EYE // BETA —